sNN0031 infusion solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for sNN0031 infusion solution, covering 2016-01-27 to 2016-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD [Phase 1, Phase 2]